1·We treated 33 cases of acute granulocytopenia caused by drugs in recent 10 years.
近10年我院收治药物所致急性粒细胞减少症33例。
2·The use of granulocyte colony-stimulating factor to prevent granulocytopenia was not permitted.
试验中不预防使用粒细胞集落刺激因子。
3·The presence of granulocytopenia or thrombocytopenia at the start of treatment does not contraindicate vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少，并不表示不适用长春花碱。
4·The presence of granulocytopenia or thrombocytopenia at the start of treatment does not contraindicate Vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少，并不禁忌用长春新碱治疗。
5·Thee presence of granulocytopenia or thrombocytopenia at the start of treatment does not contraindicate Vincristin therapy.
治疗开始时出现粒细胞减少或血小板减少，并不禁忌用长春新碱治疗。
6·To clarify the onset, development, clinical manifestations and management of propylthiouracil (PTU) -induced granulocytopenia.
目的了解丙基硫氧嘧啶(PTU)致粒细胞减少症的发病情况、临床表现及治疗对策。
7·Thus, leukemic patients are prone to anemia, thrombocytopenia, and granulocytopenia and all of the complications that ensue, particularly complications of bleeding and infection.
因此，白血病病人有贫血、血小板减少、粒细胞减少和所有继发并发症的倾向，明显的并发症是出血和感染。
8·Objective To observe the curative effect and side effect of maxipime(cefepime) in treating infection caused by postchemotherapeutic granulocytopenia in patients with acute leukemia.
目的观察马斯平应用于急性白血病化疗后粒细胞缺乏并感染的疗效和不良反应。